[Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy] (Q82036376)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

[Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

E Kilic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K Milde-Langosch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

V Müller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

R Wirtz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Ihnen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

29 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

347-352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18810438%20AND%20SRC:MED&resulttype=core&format=json

ALCAM (CD166): its role in hematopoietic and endothelial development.

14 January 2020

cites work

1 reference

12 December 2020

Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion.

1 reference

12 December 2020

Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration

1 reference

12 December 2020

Clinical relevance of prognostic factors in axillary node-negative breast cancer

1 reference

12 December 2020

ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.

1 reference

12 December 2020

Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator

1 reference

12 December 2020

Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin

1 reference

12 December 2020

ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival

1 reference

12 December 2020

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.

1 reference

12 December 2020

Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin

1 reference

12 December 2020

Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype

1 reference

12 December 2020

Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team

1 reference

12 December 2020

Molecular basis of invasion in breast cancer.

1 reference

12 December 2020

Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer

1 reference

12 December 2020

MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma

1 reference

12 December 2020